Chromoblastomycosis: An overview of clinical manifestations, diagnosis and treatment

Medical Mycology

Volumn 47, Issue 1, 2009, Pages 3-15

  Queiroz Telles, Flavio ^a   Esterre, Phillippe ^b   Perez Blanco, Maigualida ^c   Vitale, Roxana ^d   Salgado, Claudio Guedes ^e   Bonifaz, Alexandro ^f  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b INSTITUT PASTEUR DE LA GUYANE   (French Guiana)

^c Universidad Nacional Experimental Francisco de Miranda   (Venezuela)

^d CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^e UNIVERSIDADE DO ESTADO DO PARÁ   (Brazil)

^f HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

Chromoblastomycosis; Chromomycosis; Clinical; Diagnosis; Treatment

Indexed keywords

AJOENE; AMPHOTERICIN B; ERGOCALCIFEROL; FLUCONAZOLE; FLUCYTOSINE; FLUOROURACIL; FUNGAL DNA; ITRACONAZOLE; KETOCONAZOLE; POSACONAZOLE; POTASSIUM IODIDE; RIBOSOME DNA; TERBINAFINE; TIABENDAZOLE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; CARBON DIOXIDE LASER; CHROMOMYCOSIS; CLINICAL FEATURE; CLINICAL TRIAL; CRYOSURGERY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG COST; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FONSECAEA PEDROSOI; FUNGICIDAL ACTIVITY; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HISTOPATHOLOGY; HUMAN; HYPERTHERMIC THERAPY; LABORATORY DIAGNOSIS; LIMB AMPUTATION; LONG TERM CARE; LOW DRUG DOSE; MONOTHERAPY; NONHUMAN; POLYMERASE CHAIN REACTION; RECOMMENDED DRUG DOSE; REVIEW; SKIN BIOPSY; SKIN CARCINOMA; SKIN SURGERY; SQUAMOUS CELL CARCINOMA; SYSTEMIC THERAPY; TREATMENT RESPONSE; TROPICS;

AGED; ANTIFUNGAL AGENTS; ASCOMYCOTA; CHROMOBLASTOMYCOSIS; HAND DERMATOSES; HUMANS; LEG DERMATOSES; MALE;

CLADOPHIALOPHORA CARRIONII; FONSECAEA PEDROSOI; FUNGI;

EID: 58149181445     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802538001     Document Type: Review

References (106)

1. McGinnis, MR. (1983) Chromoblastomycosis and phaeohyphomycosis: New concepts, diagnosis, and mycology. J Am Acad Dermatol, 8, pp. 1-16.
2. Queiroz-Telles, F., McGinnis, MR, Salkin, I. and Graybill, JR. (2003) Subcutaneous mycoses. Infect Dis Clin North Am, 17, pp. 59-85.
3. Revankar, SG. (2006) Phaeohyphomycosis. Infect Dis Clin North Am, 20, pp. 609-620.
4. Silveira, F. and Nucci, M. (2001) Emergence of black moulds in fungal disease: Epidemiology and therapy. Curr Opin Infect Dis, 14, pp. 679-684.
5. Lupi, O., Tyring, SK and McGinnis, MR. (2005) Tropical dermatology: fungal tropical diseases. J Am Acad Dermatol, 53, pp. 931-951.
6. Castro, RM and Castro, LG. (1987) On the priority of description of chromomycosis. Mykosen, 30, pp. 397-403.
7. Rudolph, M. (1914) Über die brasilianische 'Figueira' (Vorlaufige Mitteilung). Archiev Schiffs und Tropen-Hyg, 18, pp. 498-499.
8. Pedroso, A GJM. (1920) 4 casos de dermatite verrucosa produzida pela Phialophora verrucosa. Ann Paulistas de Medicina e Cirurgia, 11, pp. 53-61.
9. Terra, F., Torres, M., Fonseca, O. and Area Leao, AE. (1922) Novo typo de dermatite verrucosa mycose por Achroteca com associação de leishmaniose. Brazil Med, 36, pp. 363-368.
10. Odds, FC, Arai, T., Disalvo, AF Evans, EG et al. (1992) Nomenclature of fungal diseases: A report and recommendations from a Sub-Committee of the International Society for Human and Animal Mycology (ISHAM). J Med Vet Mycol, 30, pp. 1-10.
11. Rippon, JW. (1982) Chromoblastomycosis and related dermal infections caused by dematiaceous fungi. Medical Mycology. The Pathogenic Fungi and the Pathogenic Actinomycetes, pp. 249-276. WB Saunders, Philadelphia
12. Matsumoto, T., Matsuda, T., McGinnis, MR and Ajello, L. (1993) Clinical and mycological spectra of Wangiella dermatitidis infections. Mycoses, 36, pp. 145-155.
13. Ainsworth and Bisby's Dictionary of the Fungi (2001) CABI Bioscience Publishers, Engham, UK
14. Hernandez-Hernandez, F., Camacho-Arroyo, I. Cerbon, MA et al. (1995) Sex hormone effects on Phialophora verrucosa in vitro and characterization of progesterone receptors. J Med Vet Mycol, 33, pp. 235-239.
15. Londero, AT and Ramos, CD. (1976) Chromomycosis: A clinical and mycologic study of thirty-five cases observed in the hinterland of Rio Grande do Sul, Brazil. Am J Trop Med Hyg, 25, pp. 132-135.
16. Tsuneto, LT, Arce-Gomez, B., Petzl-Erler, ML and Queiroz-Telles, F. (1989) HLA-A29 and genetic susceptibility to chromoblastomycosis. J Med Vet Mycol, 27, pp. 181-185.
17. Bayles, MA. (1986) Bailliere's Clinical Tropical Medicine and Comunicable Diseases. Tropical Fungal Infections, pp. 45-70. WB Saunders, London
18. Esterre, P., Andriantsimahavandy, A., Ramarcel, ER and Pecarrere, JL. (1996) Forty years of chromoblastomycosis in Madagascar: A review. Am J Trop Med Hyg, 55, pp. 45-47.
19. Bonifaz, A., Carrasco-Gerard, E. and Saul, A. (2001) Chromoblastomycosis: Clinical and mycologic experience of 51 cases. Mycoses, 44, pp. 1-7.
20. Minotto, R., Bernardi, CD, Mallmann, LF, Edelweiss, MI and Scroferneker, ML. (2001) Chromoblastomycosis: A review of 100 cases in the state of Rio Grande do Sul, Brazil. J Am Acad Dermatol, 44, pp. 585-592.
21. Perez-Blanco, M., Hernandez Valles, R, Garcia-Humbria, L. and Yegres, F. (2006) Chromoblastomycosis in children and adolescents in the endemic area of the Falcon State, Venezuela. Med Mycol, 44, pp. 467-471.
22. Silva, JP, De, SW and Rozental, S. (1998) Chromoblastomycosis: A retrospective study of 325 cases on Amazonic Region (Brazil). Mycopathologia, 143, pp. 171-175.
23. Attapattu, MC. (1997) Chromoblastomycosis-a clinical and mycological study of 71 cases from Sri Lanka. Mycopathologia, 137, pp. 145-151.
24. Leslie, DF and Beardmore, GL. (1979) Chromoblastomycosis in Queensland: a retrospective study of 13 cases at the Royal Brisbane Hospital. Australas J Dermatol, 20, pp. 23-30.
25. Rajendran, C., Ramesh, V. Misra, RS et al. (1997) Chromoblastomycosis in India. Int J Dermatol, 36, pp. 29-33.
26. Lopez, MR and Mendez Tovar, LJ. (2007) Chromoblastomycosis. Clin Dermatol, 25, pp. 188-194.
27. Sonck, CE. (1959) Chromoblastomycosis: Five cases from Finland. Acta Derm Venereol, 39, pp. 300-309.
28. Schell, WA and Esterre, P. (2006) Mycology Reference Book, Hodder Arnold, London
29. Borelli, D. (1972) Acrotheca aquaspersa nova, new species agent of chromomycosis. Acta Cient Venez, 23, pp. 193-196.
30. Barba-Gomez, JF, Mayorga, J., McGinnis, MR and Gonzalez-Mendoza, A. (1992) Chromoblastomycosis caused by Exophiala spinifera. J Am Acad Dermatol, 26, pp. 367-370.
31. Naka, W., Harada, T., Nishikawa, T. and Fukushiro, R. (1986) A case of chromoblastomycosis: With special reference to the mycology of the isolated Exophiala jeanselmei. Mykosen, 29, pp. 445-452.
32. Padhye, AA and Ajello, L. (1987) A case of chromoblastomycosis with special reference to the mycology of the isolated Exophiala jeanselmei. Mykosen, 30, p. 134.
33. Chowdhary, A., Guarro, J., Randhawa, HS Gene, J. et al. (2008) A rare case of chromoblastomycosis in a renal transplant recipient caused by a non-sporulating species of Rhytidhysteron. Med Mycol, 46, pp. 163-166.
34. Piepenbring, M., Caceres Mendez, OA Espino Espinoza, AA et al. (2007) Chromoblastomycosis caused by Chaetomium funicola: A case report from Western Panama. Br J Dermatol, 157, pp. 1025-1029.
35. Redondo-Bellon, P., Idoate, M., Rubio, M. and Ignacio, HJ. (1997) Chromoblastomycosis produced by Aureobasidium pullulans in an immunosuppressed patient. Arch Dermatol, 133, pp. 663-664.
36. Harada, S., Ueda, T. and Kusunoki, T. (1976) Systemic chromomycosis. J Dermatol, 3, pp. 13-17.
37. Salem, FA, Kannangara, DW and Nachum, R. (1983) Cerebral chromomycosis. Arch Neurol, 40, pp. 173-174.
38. Vyas, MC, Joshi, YR, Bhargava, N., Joshi, KR and Tanwar, RK. (2000) Cerebral chromoblastomicosis-a rare case report of cerebral abscess and brief review of literature-a case report. Indian J Pathol Microbiol, 43, pp. 81-85.
39. Wackym, PA, Gray Jr, GF, Richie, RE and Gregg, CR. (1985) Cutaneous chromomycosis in renal transplant recipients. Successful management in two cases. Arch Intern Med, 145, pp. 1036-1037.
40. de Hoog, GS, Queiroz-Telles, F. Haase, G. et al. (2000) Black fungi: clinical and pathogenic approaches. Med Mycol, 38, pp. 243-250.
41. Esterre, P. and Queiroz-Telles, F. (2006) Management of chromoblastomycosis: Novel perspectives. Curr Opin Infect Dis, 19, pp. 148-152.
42. De Hoog, GS, Attili-Angelis, D., Vicente, VA, Van Den Ende, AH and Queiroz-Telles, F. (2004) Molecular ecology and pathogenic potential of Fonsecaea species. Med Mycol, 42, pp. 405-416.
43. Takei, H., Goodman, JC and Powell, SZ. (2007) Cerebral phaeohyphomycosis caused by Cladophialophora bantiana and Fonsecaea monophora: Report of three cases. Clin Neuropathol, 26, pp. 21-27.
44. Surash, S., Tyagi, A. De Hoog, GS et al. (2005) Cerebral phaeohyphomycosis caused by Fonsecaea monophora. Med Mycol, 43, pp. 465-472.
45. Rubin, HA, Bruce, S., Rosen, T. and McBride, ME. (1991) Evidence for percutaneous inoculation as the mode of transmission for chromoblastomycosis. J Am Acad Dermatol, 25, pp. 951-954.
46. Salgado, CG, da Silva, JP Diniz, JA et al. (2004) Isolation of Fonsecaea pedrosoi from thorns of Mimosa pudica, a probable natural source of chromoblastomycosis. Rev Inst Med Trop Sao Paulo, 46, pp. 33-36.
47. Arango, M., Jaramillo, C., Cortes, A. and Restrepo, A. (1998) Auricular chromoblastomycosis caused by Rhinocladiella aquaspersa. Med Mycol, 36, pp. 43-45.
48. Londero, AT, Ramos, CD Fischman, O. et al. (1968) Primary chromoblastomycosis of the nose. Hospital (Rio J), 74, pp. 625-630.
49. Zaror, L., Fischman, O. Pereira, CA et al. (1987) A case of primary nasal chromoblastomycosis. Mykosen, 30, pp. 468-471.
50. Ogawa, MM, Alchorne, MM Barbieri, A. et al. (2003) Lymphoscintigraphic analysis in chromoblastomycosis. Int J Dermatol, 42, pp. 622-625.
51. Takase, T., Baba, T. and Uyeno, K. (1988) Chromomycosis. A case with a widespread rash, lymph node metastasis and multiple subcutaneous nodules. Mycoses, 31, pp. 343-352.
52. Pardo-Castelo, V., Leon, R. and Trespalacios, F. (1942) Chromoblastomycosis in Cuba. Arch Dermatol Syphilography, 65, pp. 19-32.
53. Lavalle, P. (1975) Clinical Tropical Dermatology, pp. 36-41. Blackwell Scientific Publications, London
54. Carrion, AL. (1950) Chromoblastomycosis. Ann N Y Acad Sci, 50, pp. 1255-1282.
55. Queiroz-Telles, F., Purim, KS Fillus, JN et al. (1992) Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi. Int J Dermatol, 31, pp. 805-812.
56. Restrepo, A., Gonzalez, A., Gomez, I., Arango, M. and de, BC. (1988) Treatment of chromoblastomycosis with itraconazole. Ann N Y Acad Sci, 544, pp. 504-516.
57. Esterre, P., Pecarrere, JL, Raharisolo, C. and Huerre, M. (1999) Esquamous cell carcinoma arising from chromomycosis. Report of two cases. Ann Pathol, 19, pp. 516-520.
58. Foster, HM and Harris, TJ. (1987) Malignant change (esquamous carcinoma) in chronic chromoblastomycosis. Aust N Z J Surg Oct, 57, pp. 775-757.
59. Zaias, N. (1978) Chromomycosis. J Cutan Pathol, 5, pp. 155-164.
60. Zaias, N. and Rebell, G. (1973) A simple and accurate diagnostic method in chromoblastomycosis. Arch Dermatol, 108, pp. 545-546.
61. Lee, MW, Hsu, S. and Rosen, T. (1998) Spores and mycelia in cutaneous chromomycosis. J Am Acad Dermatol, 39, pp. 850-852.
62. Salfelder, K., de Liscano, TR and Sauerteig, E. (1990) Atlas of Fungal Pathology, pp. 145-150.
63. Correa, GP, d'Avila, S., Pagliari, C. and Duarte, MIS. (2002) The cell-mediated immune reaction in the cutaneous lesion of chromoblastomycosis and their correlation with different clinical forms of the disease. Mycopathologia, 156, pp. 51-60.
64. Padhye, AA, Hampton, AA Hampton, MT et al. (1996) Chromoblastomycosis caused by Exophiala spinifera. Clin Infect Dis, 22, pp. 331-335.
65. de Andrade, TS, Cury, AE, de Castro, LG, Hirata, MH and Hirata, RD. (2007) Rapid identification of Fonsecaea by duplex polymerase chain reaction in isolates from patients with chromoblastomycosis. Diagn Microbiol Infect Dis, 57, pp. 267-272.
66. Abliz, P., Fukushima, K., Takizawa, K. and Nishimura, K. (2004) Specific oligonucleotide primers for identification of Cladophialophora carrionii, a causative agent of chromoblastomycosis. J Clin Microbiol, 42, pp. 404-407.
67. Esterre, P., Jahevitra, M. and Andriantsimahavandy, A. (2000) Humoral immune response in chromoblastomycosis during and after therapy. Clin Diagn Lab Immunol, 7, pp. 497-500.
68. Vidal, MS, de Castro, LG, Cavalecate, SC and Lacaz, CS. (2003) Immunoprecipitation techniques and Elisa in the detection of anti-Fonsecaea pedrosoi antibodies in chromoblastomycosis. Rev Inst Med Trop Sao Paulo, 45, pp. 315-318.
69. Vidal, MS, Castro, LG, Cavalcante, SC and Lacaz, CS. (2004) Highly specific and sensitive, immunoblot-detected 54 kDa antigen from Fonsecaea pedrosoi. Med Mycol, 42, pp. 511-515.
70. Oberto-Perdigon, L., Romero, H., Perez-Blanco, M. and Pitz-Castro, R. (2005) An ELISA test for the study of the therapeutic evolution of chromoblastomycosis by Cladophialophora carrionii in the endemic area of Falcon State, Venezuela]. Rev Iberoam Micol, 22, pp. 39-43.
71. Castro, LG. (1992) Chromomycosis: A therapeutic challenge. Clin Infect Dis, 15, pp. 553-554.
72. Restrepo, A. (1994) Treatment of tropical mycoses. J Am Acad Dermatol, 31, pp. S91-S102.
73. Hazen, KC. (1998) Fungicidal versus fungistatic activity of terbinafine and itraconazole: An in vitro comparison. J Am Acad Dermatol, 38, pp. S37-S41.
74. McGinnis, MR and Pasarell, L. (1998) In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi. Med Mycol, 36, pp. 243-246.
75. Andrade, TS, Castro, LG Nunes, RS et al. (2004) Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents. Mycoses, 47, pp. 216-221.
76. McBurney, EI. (1982) Chromoblastomycosis treatment with ketoconazole. Cutis, 30, pp. 746-748.
77. Olle-Goig, JE and Domingo, J. (1983) A case of chromomycosis treated with thiabendazole. Trans R Soc Trop Med Hyg, 77, pp. 773-774.
78. McGinnis, MR and Pasarell, L. (1998) In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications. J Clin Microbiol, 36, pp. 2353-2355.
79. Bonifaz, A., Saul, A., Paredes-Solis, V., Araiza, J. and Fierro-Arias, L. (2005) Treatment of chromoblastomycosis with terbinafine: Experience with four cases. J Dermatolog Treat, 16, pp. 47-51.
80. Esterre, P., Inzan, CK Ramarcel, ER et al. (1996) Treatment of chromomycosis with terbinafine: Preliminary results of an open pilot study. Br J Dermatol, 134, pp. 33-36.
81. Xibao, Z., Changxing, L., Quan, L. and Yuqing, H. (2005) Treatment of chromoblastomycosis with terbinafine: A report of four cases. J Dermatolog Treat, 16, pp. 121-124.
82. Gupta, AK, Taborda, PR and Sanzovo, AD. (2002) Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil. Med Mycol, 40, pp. 529-534.
83. Pradinaud, R. and Bolzinger, T. Treatment of chromoblastomycosis. J Am Acad Dermatol, 25, pp. 869-870.
84. Grant, SM and Clissold, SP. (1989) Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs, 37, pp. 310-344.
85. Queiroz-Telles, F., Purim, KS Boguszewski, CL et al. (1997) Adrenal response to corticotrophin and testosterone during long-term therapy with itraconazole in patients with chromoblastomycosis. J Antimicrob Chemother, 40, pp. 899-902.
86. Esterre, P., Risteli, L. and Ricard-Blum, S. (1998) Immunohistochemical study of type I collagen turn-over and of matrix metalloproteinases in chromoblastomycosis before and after treatment by terbinafine. Pathol Res Pract, 194, pp. 847-853.
87. Bonifaz, A., Paredes-Solis, V. and Saul, A. (2004) Treating chromoblastomycosis with systemic antifungals. Expert Opin Pharmacother, 5, pp. 247-254.
88. Arenas, R. (1990) Antifungal Drug Therapy: A Complete Guide for the Practitioner, pp. 43-50. Marcel-Dekker, New York
89. Pavlidakey, GP, Snow, SN and Mohs, FE. (1986) Chromoblastomycosis treated by Mohs micrographic surgery. J Dermatol Surg Oncol, 12, pp. 1073-1075.
90. Hira, K., Yamada, H., Takahashi, Y. and Ogawa, H. (2002) Successful treatment of chromomycosis using carbon dioxide laser associated with topical heat applications. J Eur Acad Dermatol Venereol, 16, pp. 273-275.
91. Kuttner, BJ and Siegle, RJ. (1986) Treatment of chromomycosis with a CO2 laser. J Dermatol Surg Oncol, 12, pp. 965-968.
92. Tagami, H., Ohi, M., Aoshima, T. Moriguchi, M. et al. (1979) Topical heat therapy for cutaneous chromomycosis. Arch Dermatol, 115, pp. 740-741.
93. Tagami, H., Ginoza, M. Imaizumi, S. et al. (1984) Successful treatment of chromoblastomycosis with topical heat therapy. J Am Acad Dermatol, 10, pp. 615-619.
94. Yanase, K. and Yamada, M. (1978) Pocket-warmer' therapy of chromomycosis [letter]. Arch Dermatol, 114, p. 1095.
95. Hiruma, M., Kawada, A., Yoshida, M. and Kouya, M. (1993) Hyperthermic treatment of chromomycosis with disposable chemical pocket warmers. Report of a successfully treated case, with a review of the literature. Mycopathologia, 122, pp. 107-114.
96. Bonifaz, A., Martinez-Soto, E., Carrasco-Gerard, E. and Peniche, J. (1997) Treatment of chromoblastomycosis with itraconazole, cryosurgery, and a combination of both. Int J Dermatol, 36, pp. 542-547.
97. Kullavanijaya, P. and Rojanavanich, V. (1995) Successful treatment of chromoblastomycosis due to Fonsecaea pedrosoi by the combination of itraconazole and cryotherapy. Int J Dermatol, 34, pp. 804-807.
98. Castro, LG, Pimentel, ER and Lacaz, CS. (2003) Treatment of chromomycosis by cryosurgery with liquid nitrogen: 15 years' experience. Int J Dermatol, 42, pp. 408-412.
99. Bopp, C. (1976) Therapy of chromoblastomycosis with a new method]. Med Cutan Ibero Lat Am, 4, pp. 285-292.
100. Kumarasinghe, SP and Kumarasinghe, MP. (2000) Itraconazole pulse therapy in chromoblastomycosis. Eur J Dermatol, 10, pp. 220-222.
101. Tanuma, H., Hiramatsu, M. Mukai, H. et al. (2000) Case report. A case of chromoblastomycosis effectively treated with terbinafine. Characteristics of chromoblastomycosis in the Kitasato region, Japan. Mycoses, 43, pp. 79-83.
102. Hay, RJ. (1999) Therapeutic potential of terbinafine in subcutaneous and systemic mycoses. Br J Dermatol, 56, pp. 36-40.
103. Sevigny, GM and Ramos-Caro, FA. (2000) Treatment of chromoblastomycosis due to Fonsecaea pedrosoi with low-dose terbinafine. Cutis, 66, pp. 45-46.
104. Shear, N., Drake, L., Gupta, AK, Lambert, J. and Yaniv, R. (2000) The implications and management of drug interactions with itraconazole, fluconazole and terbinafine. Dermatology, 201, pp. 196-203.
105. Perez-Blanco, M., Hernandez Valles, R, Zeppenfeldt, GF and Apitz-Castro, R. (2003) Ajoene and 5-fluorouracil in the topical treatment of Cladophialophora carrionii chromoblastomycosis in humans: A comparative open study. Med Mycol, 41, pp. 517-520.
106. Negroni, R., Tobon, A. Bustamante, B. et al. (2005) Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo, 47, pp. 339-346.